Using Patient-Specific Induced Pluripotent Stem Cells and Wild-Type Mice to Develop a Gene Augmentation-Based Strategy to Treat CLN3-Associated Retinal Degeneration.
暂无分享,去创建一个
E. Stone | B. Tucker | E. Burnight | R. Mullins | L. A. Wiley | A. Drack | J. S. East | Erin R. Burnight | C. Cranston | Robert A Madumba | Bailey B Banach | D. Ochoa | Jade S. East